Saltar al contenido
Merck

Saltar a

BPS60310

PDE1A Assay Kit

Sinónimos:

Assay Kits, PDE1A

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas
Talla/SKUDisponibilidadPrecio

Acerca de este artículo

UNSPSC Code:
41121811
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


manufacturer/tradename

BPS Bioscience

technique(s)

activity assay: suitable (Fluorescence Polarization)

UniProt accession no.

shipped in

dry ice

storage temp.

-65 to -96°C

General description

The PDE1A Assay Kit is designed for identification of PDE1A inhibitors using fluorescence polarization. The assay is based on the binding of a fluorescent nucleotide monophosphate generated by PDE1A1 to the binding agent. The key to the PDE1A Assay Kit is the specific binding agent. Using this kit, only two simple steps on a microtiter plate are required for PDE1A reactions. First, the fluorescently labeled cAMP is incubated with a sample containing PDE1A1 for 1 hour. Second, a binding agent is added to the reaction mix to produce a change in fluorescent polarization. The FP signal is measured using a fluorescent microplate reader capable of measuring fluorescence polarization.

Application

Study enzyme kinetics and screen small molecule inhibitors for drug discovery in high throughput screening (HTS) applications.Phosphodiesterases (PDEs) play an important role in the dynamic regulation of the second messengers cAMP (cyclic adenosine monophosphate) and cGMP (cyclic guanosine monophosphate) signaling, by hydrolyzing them. The PDE superfamily is composed of 11 families, with PDE4, 7 and 8 being cAMP-specific hydrolases, and thus regulating positive and negative responses to it. Among the 11 different families of PDEs, phosphodiesterase 1 (PDE1) sub-family of enzymes hydrolyze both cAMP and cGMP in a mutually competitive manner. The catalytic activity of PDE1 is stimulated by their binding to Ca2+/calmodulin, resulting in the integration of Ca2+ and cyclic nucleotide-mediated signaling in various diseases. The PDE1 family includes three subtypes, PDE1A, PDE1B and PDE1C, which differ for their relative affinities for cAMP and cGMP. These isoforms are differentially expressed throughout the body, including the cardiovascular, central nervous system and other organs. PDE1A increases vascular contraction of mesenteric arteries upon angiotensin II infusion in rats and also regulates cGMP hydrolysis in cardiomyocyte and vascular smooth muscle cells, which in turn controls smooth muscle tone. Inhibition of PDE1A attenuates adverse cardiac remodeling and may serve as a novel therapeutic approach to limit nitrate tolerance.
Datasheet and Protocols may be found here.

Features and Benefits

The PDE1A inhibitor screening assay kit comes in a convenient 96-well format, including purified PDE1A1 enzyme, fluorescently labeled PDE1A substrate (cAMP), binding agent, and PDE assay buffer for 100 enzyme reactions.


Pictogramas

Corrosion

Palabra de advertencia

Danger

Códigos de peligro

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B

Clase de almacenamiento

8A - Combustible corrosive hazardous materials

WGK

WGK 2



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos